+91 88 66 00 3636
+91 88 66 11 3636
- Editorial Board
Author Guidelines
- Past Issues
- Publication ethics
- PUBLISH YOUR PAPER IN 3 WORKING DAYS
Upload your Article
- Book Publication
- Current Issue
- Subscription Form
- Peer Review Process
- Sister Journals
About Us - GJRA
- Aim and Scope
- Editorial and Peer Review Processes
- Editorial Board Members
- Experience Of Editorial Board Members
- Guidelines for Authors
- Open Access
- Conflict of interest and funding
- Human and Animal Rights
- Inform Consent
- Copyright assignment
- Why Publish Your Article in Global Journal For Research Analysis
- Advertising polices for print and web publications
Global Journal For Research Analysis (GJRA) is a double reviewed monthly print journal that accepts research works from scholars, academicians, professors, doctorates, lecturers, and corporate in their respective expertise of studies. Work after publication will be retrievable on the website bifurcated based on issues of the month and its publication date. Moreover, the journal serves the research world since October, 2011.
The journal is wide and available for diverse intellectual and educational pursuit from all corners of the society to enrich the learning experience of the group readers.
The periphery of the subject areas includes:
| Accountings | Finance |
| Management Accounting | Business |
| Commerce | Corporate Governance |
| Financial Accounting | Arts |
| Fine Arts | Designing |
| Medical | Bio-medical |
| clinical research | home science |
| Medical science | Psychology |
| Human ideology | Sociology |
| Economics | Education |
| Engineering | Electronics |
| Electrical | Information technology |
| Computer Science | Management |
| Organization behaviour | Organization psychology |
| Marketing management | Law |
| Corporate | Human Resources |
| Geography | History |
| Intellectual Property Rights | Industrial Laws |
| Journalism | Literature |
| Philosophy | Pharmaceutical Science |
| Political Science | Rural India |
| Statistics | Social Sciences |
Global Journal For Research Analysis a double blind peer review. Referees remain anonymous for the author during the review procedure and the authors name is removed from the manuscript under review.
Only after publication, and only with the permission of the referee, the names of the reviewers are published in the article.
Each article is first assessed by two of the editors of the editorial board and, if it is judged suitable for GJRA, it is sent to two or three external referees for a double blind peer review. GJRA uses three different review forms (Research and Theory, Integrated Care Cases, Policy papers) all of which apply scientific criteria and take account of the purpose of the article and its merits for integrated care.
Based on the recommendations of the reviewers, the editors then decide whether the paper should be accepted as is, revised or rejected. In case of revisions, a final decision on publication will be made after resubmission. If there is no agreement on the part of the editors, the editor-in-chief will make the final decision.
We have mention our Editorial Board Members name here: Editorial Board Members
Our Editorial board members having minimum 10 years of rich experience in scholarly publishing in general and life science.
Format & Style:
Manuscripts:
All manuscripts must be printed in letter quality (font size 12) in double space on one side of A4 paper with margins of at least one inch on all sides.
Cover Page:
Manuscripts of a paper should have a cover page providing the title of the paper, the name(s), address, phone, fax numbers and e-mail address of all authors and acknowledgments, if any. Please restrict the author related information only to cover page. Further, please mention the subject under which the paper should be included.
Following the cover page, there should be an "abstract" page, which should contain the title of paper, the subtitle "Abstract" and a summary of the paper in double space. It should not exceed 150 words in length along with three to four key words. The text of the paper should not start on this page, but on a fresh page. References should be cited in the style prescribed in the publication manual of the American Psychological Association (APA Guidelines). Please visit URL: http://www.library.cornell.edu/resrch/citmanage/apa
Figures & Tables:
Each figure/table should be numbered, titled. The position of figure or table should be indicated in the text on a separate line with the words "Table 1 about here"
Length of the Papers:
The total length of the paper should not exceed 2000 words (Includes maximum 2 to 3 charts/table/figures in total, paper with more charts/table/figure shall have to pay atleast Rs.500/- extra). For every additional 750 words an extra Rs. 500/- will be charged.
Publication Fees:
GJRA charges a humble amount towards publication fees of Rs. 1500/- for single author upto 2000 words, for every Addition author Rs. 500/- extra to be paid and/or for every additional 750 words Rs.500 extra, to be paid.
For International Authors (Authors outside India) needs to pay US$ 100 for single author for an article with a length of 2000 words. However, for every additional author US$ 50 extra to be paid and/or every additional 750 words an extra US$ 50 needs to be paid.
Open access publishing The JIAS is an open access publication and its content is therefore free for anybody to access online, to read and download, as well as to copy and disseminate for educational purposes. Articles are published immediately upon acceptance and production of the final formatted version. When published online
We have indexed in following Indexing sites
| Google Scholar | Index Copernicus(ICV: 74.50) |
| IISS | DJOF |
| DRJI | Cite Factor |
| ISI | Genamics |
| EZ3 | Open J-Gate |
| Cross Ref | I2OR |
| International Socity of Universal Research in Sciences | |
Authors are responsible for recognizing and disclosing financial and other conflicts of interest that might bias their work. They should acknowledge in the manuscript all financial support for the work and other financial or personal connections to the work.
Public trust in the peer review process and the credibility of published articles depend in part on how well conflict of interest is handled during writing, peer review, and editorial decision making. Conflict of interest exists when an author (or the authors institution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from those with negligible potential to those with great potential to influence judgment, and not all relationships represent true conflict of interest. The potential for conflict of interest can exist whether or not an individual believes that the relationship affects his or her scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself. However, conflicts can occur for other reasons, such as personal relationships, academic competition, and intellectual passion.
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.
Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify Individuals who provide writing assistance and disclose the funding source for this assistance.
Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.
The requirement for informed consent should be included in the journals instructions for authors. When informed consent has been obtained it should be indicated in the published article.
Papers are accepted for publication on the understanding that exclusive copyright in the paper is assigned to the Publisher. Authors are asked to sign a copyright assignment form after acceptance of their papers.
High visibility
Global Journal For Research Analysiss open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a Highly accessed graphic, which appears on the journals contents pages and search results.
Speed of publication
Global Journal For Research Analysis offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Global Journal For Research Analysis
Flexibility
Online publication in Global Journal For Research Analysis gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
All advertisements and commercially sponsored publications are independent from editorial decisions. Global Journal For Research Analysis does not endorse any product or service marked as an advertisement or promoted by a sponsor in Global Journal For Research Analysis publications. Editorial content is not compromised by commercial or financial interests, or by any specific arrangements with advertising clients or sponsors.
Global Journal For Research Analysis reserves the right to decline any type of advertising that is damaging to the brand of Global Journal For Research Analysis or is inappropriate to the content held on the Global Journal For Research Analysis network.
Global Journal For Research Analysis will not accept advertising for products or services known to be harmful to health (e.g. tobacco and alcohol products).
Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Publisher requests its removal.
Global Journal For Research Analysis will not allow any treatment-specific or drug-specific campaign to be targeted to a specific article(s) or on any page where content relates to the product(s) being advertised. (Advertisers may not link to articles using keywords; they may not target advertising for a specific product on the condition that it appear in the same location and at the same time as a specific article mentioning that product and they may not refer to an article published at the same time as the advertisement appears).
If any advert is requested outside of Global Journal For Research Analysis standard advertising positions then a request should be made to editorial who will respond with a full and final decision within two business days.
UGC CARE JOURNAL APPROVAL STATUS
Qualis approved journal-brazil, click here.
Journal Template
Latest News
Call for papers...
GJRA invites high-quality Research Papers/Articles for July-2022 Issue. ...
June Issue Released ...
Dear Colleague, June issue of Global Journal For Research Analysis is released...thank you very much for your intellectual contribution. ...
sc_online_t(1526970,"","FFFFFF");
Subscribe to our newsletter, our other journals....
An official website of the United States government
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
- Publications
- Account settings
Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .
- Advanced Search
- Journal List
- v.2018; 2018
Kidney Stone Disease: An Update on Current Concepts
Tilahun alelign.
1 Department of Microbial, Cellular and Molecular Biology, College of Natural Sciences, Addis Ababa University, P.O. Box 1176, Addis Ababa, Ethiopia
2 Department of Biology, Debre Birhan University, P.O. Box 445, Debre Birhan, Ethiopia
Beyene Petros
Kidney stone disease is a crystal concretion formed usually within the kidneys. It is an increasing urological disorder of human health, affecting about 12% of the world population. It has been associated with an increased risk of end-stage renal failure. The etiology of kidney stone is multifactorial. The most common type of kidney stone is calcium oxalate formed at Randall's plaque on the renal papillary surfaces. The mechanism of stone formation is a complex process which results from several physicochemical events including supersaturation, nucleation, growth, aggregation, and retention of urinary stone constituents within tubular cells. These steps are modulated by an imbalance between factors that promote or inhibit urinary crystallization. It is also noted that cellular injury promotes retention of particles on renal papillary surfaces. The exposure of renal epithelial cells to oxalate causes a signaling cascade which leads to apoptosis by p38 mitogen-activated protein kinase pathways. Currently, there is no satisfactory drug to cure and/or prevent kidney stone recurrences. Thus, further understanding of the pathophysiology of kidney stone formation is a research area to manage urolithiasis using new drugs. Therefore, this review has intended to provide a compiled up-to-date information on kidney stone etiology, pathogenesis, and prevention approaches.
1. Introduction
1.1. overview of kidney stones.
Kidney stones are mainly lodged in the kidney(s) [ 1 ]. Mankind has been afflicted by urinary stones since centuries dating back to 4000 B.C. [ 2 ], and it is the most common disease of the urinary tract. The prevention of renal stone recurrence remains to be a serious problem in human health [ 3 ]. The prevention of stone recurrence requires better understanding of the mechanisms involved in stone formation [ 4 ]. Kidney stones have been associated with an increased risk of chronic kidney diseases [ 5 ], end-stage renal failure [ 3 , 6 ], cardiovascular diseases [ 7 , 8 ], diabetes, and hypertension [ 9 ]. It has been suggested that kidney stone may be a systemic disorder linked to the metabolic syndrome. Nephrolithiasis is responsible for 2 to 3% of end-stage renal cases if it is associated with nephrocalcinosis [ 10 ].
The symptoms of kidney stone are related to their location whether it is in the kidney, ureter, or urinary bladder [ 11 ]. Initially, stone formation does not cause any symptom. Later, signs and symptoms of the stone disease consist of renal colic (intense cramping pain), flank pain (pain in the back side), hematuria (bloody urine), obstructive uropathy (urinary tract disease), urinary tract infections, blockage of urine flow, and hydronephrosis (dilation of the kidney). These conditions may result in nausea and vomiting with associated suffering from the stone event [ 12 ]. Thus, the treatment and time lost from work involves substantial cost imposing an impact on the quality of life and nation's economy.
1.2. Epidemiology of Kidney Stones
Globally, kidney stone disease prevalence and recurrence rates are increasing [ 13 ], with limited options of effective drugs. Urolithiasis affects about 12% of the world population at some stage in their lifetime [ 14 ]. It affects all ages, sexes, and races [ 15 , 16 ] but occurs more frequently in men than in women within the age of 20–49 years [ 17 ]. If patients do not apply metaphylaxis, the relapsing rate of secondary stone formations is estimated to be 10–23% per year, 50% in 5–10 years, and 75% in 20 years of the patient [ 15 ]. However, lifetime recurrence rate is higher in males, although the incidence of nephrolithiasis is growing among females [ 18 ]. Therefore, prophylactic management is of great importance to manage urolithiasis.
Recent studies have reported that the prevalence of urolithiasis has been increasing in the past decades in both developed and developing countries. This growing trend is believed to be associated with changes in lifestyle modifications such as lack of physical activity and dietary habits [ 19 – 21 ] and global warming [ 16 ]. In the United States, kidney stone affects 1 in 11 people [ 22 ], and it is estimated that 600,000 Americans suffer from urinary stones every year. In Indian population, about 12% of them are expected to have urinary stones and out of which 50% may end up with loss of kidney functions [ 23 ].
2. The Urinary System and Stones
The urinary filtrate is formed in the glomerulus and passes into the tubules where the volume and content are altered by reabsorption or secretions. Most solute reabsorption occurs in the proximal tubules, whereas fine adjustments to urine composition take place in the distal tubule and collecting ducts. The loop of Henle serves to concentrate urine composed of 95% water, 2.5% urea, 2.5% mixture of minerals, salts, hormones, and enzymes. In the proximal tubules, glucose, sodium, chloride, and water are reabsorbed and returned to the blood stream along with essential nutrients such as amino acids, proteins, bicarbonate, calcium, phosphate, and potassium. In the distal tubule, the salt and acid-base balance of blood is regulated [ 24 ]. The location of stones may vary as indicated in Figure 1 .
Kidney stone locations in the urinary system. (a) Adopted from [ 25 ]. (b) Adopted from [ 26 ].
3. Types of Kidney Stones
The chemical composition of kidney stones depends on the abnormalities in urine composition of various chemicals. Stones differ in size, shape, and chemical compositions (mineralogy) [ 27 ]. Based on variations in mineral composition and pathogenesis, kidney stones are commonly classified into five types as follows [ 28 ].
3.1. Calcium Stones: Calcium Oxalate and Calcium Phosphate
Calcium stones are predominant renal stones comprising about 80% of all urinary calculi [ 29 ]. The proportion of calcium stones may account for pure calcium oxalate (CaOx) (50%), calcium phosphate (CaP, termed as apatite) (5%), and a mixture of both (45%) [ 30 ]. The main constituent of calcium stones is brushite (calcium hydrogen phosphate) or hydroxyapatite [ 31 , 32 ]. Calcium oxalate is found in the majority of kidney stones and exists in the form of CaOx monohydrate (COM, termed as mineral names: whewellite, CaC 2 O 4 ·H 2 O), and CaOx dihydrate (COD, weddellite, CaC 2 O 4 ·2H 2 O), or as a combination of both which accounts for greater than 60% [ 33 ]. COM is the most thermodynamically stable form of stone. COM is more frequently observed than COD in clinical stones [ 34 ].
Many factors contribute to CaOx stone formation such as hypercalciuria (resorptive, renal leak, absorptive, and metabolic diseases), hyperuricosuria, hyperoxaluria, hypocitraturia, hypomagnesuria, and hypercystinuria [ 35 ]. Mostly, urinary pH of 5.0 to 6.5 promotes CaOx stones [ 36 ], whereas calcium phosphate stones occur when pH is greater than 7.5 [ 11 ]. The recurrence of calcium stone is greater than other types of kidney stones.
3.2. Struvite or Magnesium Ammonium Phosphate Stones
Struvite stones occur to the extent of 10–15% and have also been referred to as infection stones and triple phosphate stones. It occurs among patients with chronic urinary tract infections that produce urease, the most common being Proteus mirabilis and less common pathogens include Klebsiella pneumonia , Pseudomonas aeruginosa, and Enterobacter [ 1 , 28 , 29 ]. Urease is necessary to split/cleave urea to ammonia and CO 2, making urine more alkaline which elevates pH (typically > 7). Phosphate is less soluble at alkaline versus acidic pH, so phosphate precipitates on to the insoluble ammonium products, yielding to a large staghorn stone formation [ 37 ]. Women's are likely to develop this type of stone than the male. Escherichia coli is not capable of splitting urea and is not associated with struvite stones [ 38 ].
3.3. Uric Acid Stones or Urate
This accounts approximately for 3–10% of all stone types [ 1 , 29 ]. Diets high in purines especially those containing animal protein diet such as meat and fish, results in hyperuricosuria, low urine volume, and low urinary pH (pH < 5.05) exacerbates uric acid stone formation [ 11 , 28 , 39 ]. Peoples with gouty arthritis may form stones in the kidney(s). The most prevalent cause of uric acid nephrolithiasis is idiopathic [ 38 ], and uric acid stones are more common in men than in women.
3.4. Cystine Stones
These stones comprise less than 2% of all stone types. It is a genetic disorder of the transport of an amino acid and cystine. It results in an excess of cystinuria in urinary excretions [ 1 , 29 ], which is an autosomal recessive disorder caused by a defect in the rBAT gene on chromosome 2 [ 40 ], resulting in impaired renal tubular absorption of cystine or leaking cystine into urine. It does not dissolve in urine and leads to cystine stone formation [ 11 ]. People who are homozygous for cystinuria excrete more than 600 millimole insoluble cystine per day [ 28 ]. The development of urinary cystine is the only clinical manifestation of this cystine stone disease [ 40 ].
3.5. Drug-Induced Stones
This accounts for about 1% of all stone types [ 1 ]. Drugs such as guaifenesin, triamterene, atazanavir, and sulfa drugs induce these stones. For instance, people who take the protease inhibitor indinavir sulphate, a drug used to treat HIV infection, are at risk of developing kidney stones [ 28 ]. Such lithogenic drugs or its metabolites may deposit to form a nidus or on renal calculi already present. On the other hand, these drugs may induce the formation of calculi through its metabolic action by interfering with calcium oxalate or purine metabolisms [ 38 ].
4. Kidney Stone Compositions
The chemical compositions of urinary stones include crystals and noncrystalline phases or the organic material (the matrix). The organic matrix of urinary stones consists of macromolecules such as glycosaminoglycans (GAG's), lipids, carbohydrates, and proteins. These molecules play a significant role by promoting or inhibiting the processes of kidney stone development ( Table 1 ). The main components of the stone matrix are proteins (64%), nonamino sugars (9.6%), hexosamine as glucosamine (5%), water (10%), and inorganic ash (10.4%). The matrix acts as a template participating in the assembly of kidney stones. The matrix of all stones contains phospholipids (8.6%) of the total lipid, which in turn represents about 10.3% of stone matrix. Cell membrane phospholipids, as part of organic matrix, promote the formation of calcium oxalate and calcium phosphate stones [ 41 ]. Albumin is the major component of the matrix of all stone types [ 42 ].
Urinary stone matrix protein modulators of crystallization in nephrolithiasis [ 34 , 41 ].
| Serial Number | Name of protein | Role in crystallization | |||
|---|---|---|---|---|---|
| Nucleation | Growth | Aggregation | Cell adherence | ||
| 1 | Nephrocalcin (NC) | I | I | I | — |
| 2 | Tamm–Horsfall protein (THP) | P | — | I/P | — |
| 3 | Osteopontin/uropontin (OPN) | I | I | I | I/P |
| 4 | Albumin | P | — | I | — |
| 5 | Urinary prothrombin fragment-1 (UPTF1) | I | I | I | — |
| 6 | Alpha-1-microglobulin | — | — | I | — |
| 7 | S100A | — | I | I | — |
| 8 | Inter-alpha-inhibitor | I | I | I | I |
| 9 | Bikunin | I | I | I | I |
| 10 | Renal lithostathine | — | I | — | — |
| 11 | Alpha defensin | — | P | P | — |
| 12 | Human phosphatecytidylyl transferase 1, choline, beta | — | I | — | — |
| 13 | Myeloperoxidase | — | P | P | — |
| 14 | Nucleolin | — | — | — | P |
| 15 | Histone-lysine N methyltransferase | — | I | I | — |
| 16 | Inward rectifier K channel | — | I | I | — |
| 17 | Protein Wnt-2 | — | I | I | — |
| 18 | Alpha-2HS glycoprotein | P | I | — | — |
| 19 | Crystal adhesion inhibitor (CAI) | — | — | — | I |
| 20 | Hyaluronic acid (HA) | — | — | — | P |
| 21 | Chondroitin sulphate | — | I | I | — |
| 22 | Heparin sulphate (HS) | — | I | — | — |
| 23 | Human urinary trefoil factor 1(THF1) | — | I | — | — |
| 24 | Monocyte chemoattractant protein-1 (MCP 1) | — | — | — | P |
| 25 | Annexin II | — | — | — | P |
| 26 | CD44 | — | — | — | P |
| 27 | Matrix Gla protein (MGP) | — | I | — | I |
| 28 | Histone H1B | — | P | — | — |
| 29 | Fibronectin | — | — | I | I |
| 30 | Collagen | P | — | — | — |
| 31 | Glycosaminoglycans | I | I | I | I |
| 32 | Citrate | — | I | — | — |
| 33 | Pyrophosphate | — | I | — | — |
| 34 | Magnesium | — | I | — | — |
I: inhibitor; P: promoter; “—”: no effect.
Brushite stone is a hard phosphate mineral with an increasing incidence rate, and a quarter of calcium phosphate (CaP) patients form stones containing brushite [ 43 ]. In the urinary tract, CaP may be present in the form of hydroxyapatite, carbonate apatite, or brushite (calcium monohydrogen phosphate dihydrate, CaHPO4·2H2O). Brushite is resistant to shock wave and ultrasonic lithotripsy treatment [ 44 ].
4.1. Etiology of Kidney Stones
Formation of kidney stones (calculogenesis) is a complex and multifactorial process including intrinsic (such as age, sex, and heredity) and extrinsic factors such as geography, climate, dietary, mineral composition, and water intake [ 15 ]. A summary of possible causes of kidney stone formation is shown in Table 2 .
Risk factors associated with kidney stone formations.
| Number | Risk factors | References |
|---|---|---|
| 1 | : such as excessive intake of animal proteins and salt and deficiencies of chelating agents like citrate, fiber, and alkali foods | [ , , , ] |
| 2 | : such as hypercalciuria, hypocitraturia, hyperoxaluria, hyperuricosuria, and history of gout (defective metabolism of uric acid) | [ , – ] |
| 3 | : primary hyperparathyroidism and other disturbances of calcium metabolism | [ ] |
| 4 | : excessive excretion of promoters of urinary crystallization and reduced excretion of inhibitors (urine deficient in inhibitory substances) | [ , , ] |
| 5 | : inadequate water intake (dehydration and supersaturated urine) | [ , , ] |
| 6 | : abnormalities of urinary pH and alkalinization of urine by bacterial urease (such as ) | [ , ] |
| 7 | : family history of stones ( susceptibility); genetic monogenic diseases (single abnormal gene disorders on the autosomes); renal tubular acidosis | [ , , , , ] |
| 8 | : factors such as defects in medullary sponge kidney, ureteropelvic junction stenosis, pyeloureteral duplication, polycystic renal disease, and horseshoe kidney | [ , , , ] |
| 9 | [ ] | |
| 10 | [ – ] | |
| 11 | (global warming), occupation, geographic conditions, and seasonal variations (higher in summer than winter) | [ , ] |
| 12 | and other intestinal malabsorption or associated disease states | [ , ] |
| 13 | Absence of intestinal | [ , ] |
| 14 | : such as indinavir (Crixivan), a protease inhibitor, sulfonamides (sulfadiazine), uricosuric agents, which have low solubility andpromotes the formation of calculi, and ceftriaxone (high dose on long terms) | [ , , , ] |
5. Mechanisms of Renal Stone Formation
The pathogenesis of kidney stone or biomineralization is a complex biochemical process which remains incompletely understood [ 41 ]. Renal stone formation is a biological process that involves physicochemical changes and supersaturation of urine. Supersaturated solution refers to a solution that contains more of dissolved material than could be dissolved by the solvent under normal circumstances [ 34 ]. As a result of supersaturation, solutes precipitate in urine leads to nucleation and then crystal concretions are formed. That is, crystallization occurs when the concentration of two ions exceeds their saturation point in the solution [ 55 ]. The transformation of a liquid to a solid phase is influenced by pH and specific concentrations of excess substances. The level of urinary saturation with respect to the stone-forming constituents like calcium, phosphorus, uric acid, oxalate, cystine, and low urine volume are risk factors for crystallization [ 1 , 56 ]. Thus, crystallization process depends on the thermodynamics (that leads to nucleation) and kinetics (which comprises the rates of nucleation or crystal growth) of a supersaturated solution [ 57 ]. Therefore, lithiasis can be prevented by avoiding supersaturation.
However, it should be noted that stone formation is usually dependent on the level of imbalance between urinary inhibitors and promoters of crystallization. All stones share similar events with respect to the mineral phase of stone formation. But, the sequence of events leading to stone formation differs depending on the type of stone and urine chemistry. For instance, crystallization of calcium-based stones (calcium oxalate or calcium phosphate) occurs in supersaturated urine if it is with low concentrations of inhibitors. Uric acid interferes the solubility of calcium oxalate and promotes CaOx stone formation. In healthy controls, crystallization process is opposed by inhibitory substances and gets safe [ 1 ]. The sequence of events that trigger stone formation includes nucleation, growth, aggregation, and retention of crystals within the kidneys [ 27 , 58 ].
5.1. Crystal Nucleation
The first step in the formation of kidney stone begins by the formation of nucleus (termed as nidus) from supersaturated urine retained inside the kidneys [ 11 , 42 ]. In a supersaturated liquid, free atoms, ions, or molecules start forming microscopic clusters that precipitate when the bulk free energy of the cluster is less than that of the liquid. For example, charged soluble molecules such as calcium and oxalate combine to form calcium oxalate crystals and become insoluble [ 34 ]. Nucleation may be formed in the kidney through free particle or fixed particle mechanism [ 26 , 34 ]. In supersaturated solutions, if promoters exceed that of inhibitors, nucleation starts [ 34 ].
Once a nucleus is created (and/or if it is anchored), crystallization can occur at lower chemical pressure than required for the formation of the initial nucleus. Existing epithelial cells, urinary casts, RBCs, and other crystals in urine can act as nucleating centers in the process of nuclei formation termed as heterogeneous nucleation [ 41 ]. The organic matrix, mucopolysaccharide acts as a binding agent by increasing heterogeneous nucleation and crystal aggregation [ 59 ]. On the other hand, nanobacteria is claimed to form apatite structures serving as a crystallization center for stone formation [ 60 ]. The whole process potentiates stone formation. The role of oxalate-degrading bacteria, such as Oxalobacter formigenes , in CaOx stone formation is a subject of current research [ 61 ]. Thus, treatment which targets the process of nucleation intervention is one of the best approaches to control kidney stone.
5.2. Crystal Growth
Crystals in urine stick together to form a small hard mass of stone referred as crystal growth. Stone growth is accomplished through aggregation of preformed crystals or secondary nucleation of crystal on the matrix-coated surface [ 62 ]. Once a nidus has achieved, the overall free energy is decreased by adding new crystal components to its surface. The total free energy of the cluster is increased by the surface energy. The process of stone growth is slow and requires longer time to obstruct the renal tubules [ 34 ]. From organic matrix, mainly Tamm–Horsfall protein and osteopontin are promoters of CaOx stone formation [ 13 ]. Under in vitro study, crystals induced in human urine demonstrated an intimate association between calcium-containing crystals and organic matrix (lipids and proteins). Lipids of cellular membranes are basically believed to involve in nucleation of crystals [ 63 ].
5.3. Crystal Aggregation
The process whereby a small hard mass of a crystal in solution sticks together to form a larger stone is called aggregation. All models of CaOx urolithiasis concede that crystal aggregation is probably involved in crystal retention within the kidneys [ 41 ]. Crystal aggregation is considered to be the most critical step in stone formation.
5.4. Crystal-Cell Interaction
The attachment of grown crystals with the renal tubule lining of epithelial cells is termed as crystal retention or crystal-cell interaction [ 41 , 64 ]. In individuals with hyperoxaluria, renal tubular epithelial cells were injured due to exposure to high oxalate concentrations or sharp calcium oxalate monohydrate (COM) crystals [ 10 , 65 , 66 ]. Crystal-cell interaction results in the movement of crystals from basolateral side of cells to the basement membrane [ 10 ]. Then, crystals could be taken into cells and anchored to the basement membrane of the kidneys [ 66 ]. The interaction of COM crystals with the surface of renal epithelial cells could be a critical initiating event in nephrolithiasis. An increased retention force between the crystal and injured renal tubule epithelium cells promotes CaOx crystallization [ 67 ]. Most of the crystals attached to epithelial cells are thought to be digested by macrophages and/or lysosomes inside cells and then discharged with urine [ 66 ].
Following renal tubular cell injury, cellular degradation produces numerous membrane vesicles which are nucleators of calcium crystals as supported by in vitro and in vivo studies [ 41 ]. Injured cells release substances like renal prothrombin fragment-1 or other anionic proteins which induce COM crystal agglomeration [ 68 ]. Reactive oxygen species is thought to be one of the factors involved in renal cell injury [ 69 ]. Thus, reduction of renal oxidative stress could be an effective treatment option.
Injured cells potentiate to invert its cell membrane which is anionic to the urinary environment and acts as site of crystal adherence. COM crystals have stronger affinity of attachment towards the inverted anionic membrane [ 69 ], than calcium oxalate dihydrate (COD) crystals [ 70 ]. On the other hand, deposition of COM crystal was observed in Madin–Darby canine kidney epithelial cells (MDCK cells), than at proximal tubular epithelial cells derived from pig kidney (LLC-PK1 cells) study models [ 71 ]. This preferential difference may be due to the presence of a binding molecule such as hyaluronan on Madin–Darby canine kidney epithelial cells for COM crystal attachment [ 67 ]. Although the detailed mechanisms of crystal-cell interaction remain unexplored, one of the best ways to treat urolithiasis is to control crystal-cell retentions.
5.5. Endocytosis of CaOx Crystals
Endocytosis or engulfment of crystals by renal tubular cells is the earliest process in the formation of kidney stones. Studies on tissue culture crystal-cell interactions indicated that COM crystals rapidly adhere to microvilli on the cell surface and subsequently internalized. Polyanion molecules present in tubular fluid/urine such as glycosaminoglycans, glycoproteins, and citrate may coat crystals and inhibit the binding of COM crystals to cell membrane [ 41 ]. For example, Tamm–Horsfall glycoproteins (THP) have a dual biological role in stone formation. Lieske et al. [ 72 ] reported that THP may promote renal stone formation by initiating the interaction of COM crystals with distal tubular cells of the nephron. Another study revealed that, upon lowering pH and raising ionic strength, THP's viscosity increases which exhibits high tendency of polymerization and fails to inhibit crystallization. Moreover, THP becomes a strong promoter of crystallization in the presence of additional calcium ions [ 73 ]. In contrast, THP is thought to protect against COM stone formation by inhibiting COM aggregation when it is at high pH and low ionic strength as reported by Hess [ 73 ]. COM aggregation assays revealed that desialylated THP promoted COM aggregation, while normal THP inhibited aggregation [ 74 ]. Similar reports revealed that THP may inhibit calcium oxalate crystal aggregation, whereas uromodulin may promote aggregation [ 75 ]. Inactivating the THP gene in mouse embryonic stem cells results in spontaneous formation of calcium crystals in adult kidneys. This is a convincing evidence that THP is a critical urinary inhibitor of human nephrolithiasis [ 76 ].
Various cellular and extracellular events are involved during stone formation. Modulators targeting the steps from supersaturation to crystal retention may be a potential means to block stone formation. Similarly, the blockage of crystal binding molecules (such as osteopontin, hyaluronic acid, sialic acid, and monocyte chemoattractant protein-1) expressed on epithelial cell membranes may be an alternative approach to prevent stone formation [ 41 ]. Experimental findings demonstrated that stone calcification is triggered by reactive oxygen species (ROS) and the development of oxidative stress [ 77 ]. In vitro [ 78 , 79 ] and in vivo [ 80 , 81 ] studies have demonstrated that CaOx crystals are toxic for renal epithelial cells that produce injury and renal cell death. Similarly, an exposure to hypercalciuria produces cellular injury and ROS-induced lipid peroxidation which stimulates calcium oxalate deposition [ 82 ]. The pathophysiology of urinary stone formation is incompletely understood. A summary of the various steps involved in stone formation is shown below ( Figure 2 ).
Schematic representation of the various events of kidney stone formation.
5.6. Cell Injury and Apoptosis
Exposure to high levels of oxalate or CaOx crystals induces epithelial cellular injury, which is a predisposing factor to subsequent stone formation [ 83 , 84 ]. CaOx crystal depositions in the kidneys upregulate the expression and synthesis of macromolecules that can promote inflammation [ 85 ]. Crystals may be endocytosed by cells or transported to the interstitium. It has been suggested that injured cells develop a nidus which promotes the retention of particles on the renal papillary surface [ 86 ]. In individuals with severe primary hyperoxaluria, renal tubular cells are injured and crystals become attached to them [ 66 ]. The addition of CaOx crystals onto Madin–Darby canine kidney (MDCK) cell lines showed an increase in the release of lysosomal enzymes, prostaglandin E2, and cytosolic enzymes [ 87 ]. A study on animal models also revealed that the administration of high concentrations of CaOx crystals or oxalate ions appears to be toxic causing renal tubular cell damage [ 41 ]. It has been suggested that oxalate increases the availability of free radicals by inhibiting enzymes responsible for their degradation. For instance, reactive oxygen species can damage the mitochondrial membrane and reduce its transmembrane potential. These events are known features of early process in apoptotic pathways [ 88 ].
The activation of p38 mitogen-activated protein kinase (p38 MAPK) signaling pathway regulates the expression of cellular proteins. The various extracellular stimuli or stresses like ultraviolet radiation and proinflammatory cytokines may activate p38 MAPK which results in phosphorylation and activation of transcription factors [ 89 ]. The exposure of renal cells to oxalate increases an altered gene expression that induces apoptosis signaling cascades [ 88 ]. A study revealed that the exposure of HK-2 cells to increased oxalate levels results in an increased transcriptional activation of IL-2R beta mRNA and consequently increases IL-2R beta protein levels which drive cellular changes like induction of inflammation. Oxalate-induced activation may trigger p38 MAPK signaling by acting on cell membranes, although the exact mechanisms have not been established [ 90 ].
Apoptosis at the level of renal tubular cells may lead to stone formation through cellular demise and postapoptotic necrosis which could promote calcium crystal aggregation and growth. This fact has been supported by in vitro study on MDCK cells being exposed to oxalate ions [ 91 ]. However, it has to be noted that some cells did not respond to oxalate injury. This may be due to the fact that changes in gene expression could protect from apoptosis and then inhibit from lithiasis [ 35 ]. These findings highlight the need for future studies clarifying novel biochemical targets of kidney stone formation and the utility of p38 MAPK inhibitors in preventing stone formation.
5.7. Genetic Basis of Kidney Stone Formation
Environmental factors interacting with underlying genetic factors cause rare stone disease [ 92 ]. The production of promoters and inhibitors of crystallization depends on proper functioning of the renal epithelial cells. Cellular dysfunction affects the supersaturation of urinary excretion by influencing ions such as calcium, oxalate, and citrate [ 93 ]. Some genetic defects which lead to stone formation are shown in Table 3 .
Gene involved in hypercalciuria, gene products, and renal phenotype [ 93 ].
| Gene | Gene product/function | Renal phenotype |
|---|---|---|
| VDR | Vitamin D receptor | Decreased calcium reabsorption leading to hypercalciuria and nephrocalcinosis |
| CLCNS | Cl/H antiporter | Inactivating mutation causes hypercalciuria, hyperphosphaturia, low molecular weight proteinuria, nephrocalcinosis, stone |
| CASR | Calcium sensing receptor | Gain of function mutation produces hypercalciuria, nephrocalcinosis, stone |
| CLDN16 | Tight junction protein | Hypercalciuria, magnesium wasting, nephrocalcinosis, stone |
| NPT2a/c | Sodium phosphate cotransporter | Hypercalciuria, hypophosphatemia, phosphate wasting, nephrocalcinosis, stone |
| TRPV5 | Calcium selective transient receptor potential channel | Hypercalciuria, hyperphosphaturia |
| sAC | Soluble adenylate cyclase/bicarbonate exchanger/ | Hypercalciuria, stones |
| KLOTHO | Aging suppression protein/regulator of calcium homeostasis | Hypercalciuria |
5.8. Randall's Plaques
Randall's plaques appear to be the precursor's origin of urinary stone development although it is unclear whether it involves in all stone types or not [ 62 ]. Moreover, the pathogenesis of Randall's plaque itself is not clearly known [ 94 ]. The majority of CaOx stones are found to be attached with renal papillae at the sites of Randall's plaque [ 26 ]. It is located at the interstitial basement membrane in loop of Henle [ 95 , 96 ]. Calcium phosphate (apatite), and purine crystal compositions were identified in plaques, whereas apatite is dominant [ 97 ]. Initially, calcium phosphate crystals and organic matrix are deposited along the basement membranes of the thin loops of Henle and extend further into the interstitial space to the urothelium, constituting the so-called Randall plaques. Evidence suggests that a primary interstitial apatite crystal formation secondarily leads to CaOx stone formation [ 13 ]. In supersaturated urine, crystals adhere to the urothelium which may enhance subsequent stone growth [ 98 ].
Due to renal cell injury, plaque is exposed to supersaturated urine. Renal epithelial cell damage (degradation) products promote heterogeneous nucleation and promotes crystal adherence in renal cells. Randall plaque calcification is triggered by oxidative stress. Cells may express molecules at distal and collecting tubules which act as crystal binding sites such as phosphatidylserine, CD44, osteopontin, and hyaluronan [ 27 , 99 ]. Renal epithelial cells of the loop of Henle or collecting ducts produce membrane vesicles at the basal side which leads to plague formation [ 77 ]. Thus, apatite crystal deposits have been proposed to act as nidus for CaOx stone formation by attachment on further matrix molecules [ 13 , 77 ]. However, the driving forces in plaque formation and the involved matrix molecules remain elusive.
Kidney stones are either attached to the renal papillae or found freely [ 100 ]. According to the fixed particle pathway, the beginning of calcium phosphate (CaP) deposition in the interstitium establishes a nucleus for CaOx formation. CaP formed in the basement membrane of the loops of Henle, the inner medullary collecting ducts, and ducts of Bellini serves as an attachment site for stone development. Idiopathic stone formers develop CaOx attached to fixed sites of interstitial plaque [ 26 ]. Stones of the distal tubular acidosis attach to plugs protruding from dilated ducts of Bellini, whereas cystinuria stones do not attach to the renal plagues (found freely) [ 26 ]. CaP, uric acid, or cystine crystals formed in the renal tubules plug at the terminal collecting ducts. When mineralization reaches the renal papillary surface, plaques rupture exposing CaP crystals to the pelvic urine. Then, urinary macromolecules deposit over the exposed CaP crystals and promote CaOx deposition on CaP [ 4 ].
5.9. Kidney Stone Inhibitors and Promoters
Inhibitors are substances which decrease the initiation of supersaturation, nucleation, crystal growth, rate of aggregation, or any other processes required to stone formation [ 34 ]. Normally, urine contains chemicals that prevent crystal formation. Inhibitors in urine includes small organic anions such as citrate, small inorganic anions such as pyrophosphates, multivalent metallic cations such as magnesium, or macromolecules such as osteopontin, glycosaminoglycans, glycoproteins, urinary prothrombin fragment-1, and Tamm–Horsfall proteins [ 41 , 62 ]. These inhibitors do not seem to work equally for everyone; therefore, some people form stones. But, if crystals formed remain tiny, usually it travels through the urinary tract and passes out from the body with urine splash without being noticed. Inhibitors may act either directly by interacting with crystal or indirectly by influencing the urinary environment [ 42 ]. When inhibitory compounds adsorb onto the surface of the crystal, it inhibits nucleation, crystal growth, aggregation, or crystal-cell adherence.
In contrast, promoters are substances which facilitate stone formation by various mechanisms [ 62 ]. Some of the promoters include cell membrane lipids (phospholipids, cholesterol, and glycolipids) [ 42 ], calcitriol hormone enhancement via parathyroid hormone stimulation [ 101 ], oxalate, calcium, sodium, cystine, and low urine volume [ 34 ]. Among recurrent stone formers, urinary oxalate excretion was found to be higher, whereas citrate excretion was lower [ 102 ]. Studies indicated that oxalate can increase chloride, sodium, and water reabsorption in the proximal tubule and activate multiple signaling pathways in renal epithelial cells [ 103 ]. In general, an imbalance between urinary stone inhibitors and promoters has been suggested to be the cause for stone formation [ 34 ]. A list of substances generally considered to inhibit or promote stone formation process is shown in Table 1 .
6. Preventive Options for Urolithiasis
Effective kidney stone prevention depends upon addressing the cause of stone formation. Generally, to prevent the first episodes of kidney stone formation or its secondary episodes, proper management of diet and the use of medications is required. Primary prevention of kidney stone disease via dietary intervention is low-cost public health initiative with massive societal implications. Thus, nutritional management is the best preventive strategy against urolithiasis [ 104 ].
Regardless of the underlying etiology and drug treatment of the stone disease, patients should be instructed to increase their water intake in order to maintain a urine output of at least 2 liter per day [ 49 ]. A simple and most important lifestyle change to prevent stone disease is to drink more water/liquids. Enough fluid intake reduces urinary saturation and dilutes promoters of CaOx crystallization. Dietary recommendations should be adjusted based on individual metabolic abnormalities. For absorptive hyperoxaluria, low oxalate diet and increased dietary calcium intake are recommended [ 61 ].
A high sodium intake boosts stone risk by reducing renal tubular calcium reabsorption and increasing urinary calcium [ 105 ]. Restriction of animal proteins is also encouraged since animal proteins provide an increased acid load because of its high content of sulfur-containing amino acids. Thus, high protein intake reduces urine pH and the level of citrate and enhances urinary calcium excretion via bone reabsorption. Therefore, if you have very acidic urine, you may need to eat less meat, fish, and poultry and avoid food with vitamin D [ 106 ]. Instead, an increase intake of fruits and vegetables rich in potassium is recommended [ 49 ].
People who form calcium stones used to be told to avoid dairy products and other foods with high calcium content. However, persons with a tendency of kidney stone formation should not be advised to restrict calcium intake unless it has been known that he/she has an excessive use of calcium [ 107 ]. A reduced intake of calcium leads to an increased intestinal absorption of oxalate, which itself may account for an increased risk of stone formation. Calcium supplements may reduce oxalate absorption because the calcium binds dietary oxalate in the gut lumen. However, the benefit of taking calcium pills is controversial. Vitamin C has been implicated in stone formation because of in vivo conversion of ascorbic acid to oxalate. Therefore, a limitation of vitamin C supplementation is recommended [ 105 ].
For prevention of calcium oxalate, cystine, and uric acid stones, urine should be alkalinized by eating a diet high in fruits and vegetables, taking supplemental or prescription citrate, or drinking alkaline mineral waters. For uric acid stone formers, gout needs to be controlled, and for cystine stone formers, sodium and protein intakes need to restricted. For prevention of calcium phosphate and struvite stones, urine should be acidified. For struvite stones, acidifying the urine is the single most important step [ 108 ]. Patients must receive careful follow-up to be sure that the infection has cleared. However, the current treatment modalities are not efficient to prevent urolithiasis, and further research is required.
7. Conclusion
Despite considerable improvements in the development of new therapies for the management of urinary stones, the incidence of urolithiasis is increasing worldwide. Many aspects of renal stone formation remain unclear. However, it is certain that renal cell injury, crystal retention, cell apoptosis, Randall's plaque, and associated stone inhibitors or promoters play important roles for kidney stone formation. These seem to be critical targets that lead to developing a novel strategy to prevent kidney stone disease and drugs against kidney stones. In addition, the identification of novel treatment targets on the basis of molecular and cellular alterations in relation to stone formation will help develop better drugs. Moreover, better understanding of the mechanisms of urolithiasis associated with stone inhibitors or promoters will be critical for stone-removing medications. Furthermore, understanding the underlying pathophysiology, pathogenesis, and genetic basis of kidney stone formation will hopefully lead to discover novel drugs and strategies to manage urolithiasis in the near future.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
- Download PDF
- Share X Facebook Email LinkedIn
- Permissions
Why Should the FDA Focus on Pragmatic Clinical Research?
- 1 US Food and Drug Administration, White Oak Campus, Silver Spring, Maryland
- Editor's Note Integrating Clinical Trials and Practice Gregory Curfman, MD JAMA
- Special Communication The Integration of Clinical Trials With the Practice of Medicine Derek C. Angus, MD, MPH; Alison J. Huang, MD, MAS; Roger J. Lewis, MD, PhD; Amy P. Abernethy, MD, PhD; Robert M. Califf, MD; Martin Landray, PhD; Nancy Kass, ScD; Kirsten Bibbins-Domingo, PhD, MD, MAS; JAMA Summit on Clinical Trials Participants; Ali B Abbasi; Kaleab Z Abebe; Amy P Abernethy; Stacey J. Adam; Derek C Angus; Jamy Ard; Rachel A Bender Ignacio ; Scott M Berry; Deepak L. Bhatt; Kirsten Bibbins-Domingo; Robert O. Bonow; Marc Bonten; Sharon A. Brangman; John Brownstein; Melinda J. B. Buntin; Atul J Butte; Robert M. Califf; Marion K Campbell; Anne R. Cappola; Anne C Chiang; Deborah Cook; Steven R Cummings; Gregory Curfman; Laura J Esserman; Lee A Fleisher; Joseph B Franklin; Ralph Gonzalez; Cynthia I Grossman; Tufia C. Haddad; Roy S. Herbst; Adrian F. Hernandez; Diane P Holder; Leora Horn; Grant D. Huang; Alison Huang; Nancy Kass; Rohan Khera; Walter J. Koroshetz; Harlan M. Krumholz; Martin Landray; Roger J. Lewis; Tracy A Lieu; Preeti N. Malani; Christa Lese Martin; Mark McClellan; Mary M. McDermott; Stephanie R. Morain; Susan A Murphy; Stuart G Nicholls; Stephen J Nicholls; Peter J. O'Dwyer; Bhakti K Patel; Eric Peterson; Sheila A. Prindiville; Joseph S. Ross; Kathryn M Rowan; Gordon Rubenfeld; Christopher W. Seymour; Rod S Taylor; Joanne Waldstreicher; Tracy Y. Wang JAMA
Traditional randomized clinical trials (RCTs) have long been a key tool underpinning drug and device development. The use of individual participant randomization and active or placebo controls in RCTs, combined with comprehensive collection of highly structured data, supports assay sensitivity. At the same time, focused enrollment criteria and careful attention to the collection of adverse events for specified follow-up periods promote detection of toxicities and risks. These trials support a system, regulated by the US Food and Drug Administration (FDA) and other global regulators, that allows the majority of candidate therapies whose risks outweigh benefits for intended use to be screened out while enabling safe and effective medical products to advance to market. However, the next stage—after product development and marketing authorization are completed and a therapy is integrated into clinical practice—needs serious attention.
- Editor's Note Integrating Clinical Trials and Practice JAMA
Read More About
Abbasi AB , Curtis LH , Califf RM. Why Should the FDA Focus on Pragmatic Clinical Research? JAMA. Published online June 03, 2024. doi:10.1001/jama.2024.6227
Manage citations:
© 2024
Artificial Intelligence Resource Center
Cardiology in JAMA : Read the Latest
Browse and subscribe to JAMA Network podcasts!
Others Also Liked
Select your interests.
Customize your JAMA Network experience by selecting one or more topics from the list below.
- Academic Medicine
- Acid Base, Electrolytes, Fluids
- Allergy and Clinical Immunology
- American Indian or Alaska Natives
- Anesthesiology
- Anticoagulation
- Art and Images in Psychiatry
- Artificial Intelligence
- Assisted Reproduction
- Bleeding and Transfusion
- Caring for the Critically Ill Patient
- Challenges in Clinical Electrocardiography
- Climate and Health
- Climate Change
- Clinical Challenge
- Clinical Decision Support
- Clinical Implications of Basic Neuroscience
- Clinical Pharmacy and Pharmacology
- Complementary and Alternative Medicine
- Consensus Statements
- Coronavirus (COVID-19)
- Critical Care Medicine
- Cultural Competency
- Dental Medicine
- Dermatology
- Diabetes and Endocrinology
- Diagnostic Test Interpretation
- Drug Development
- Electronic Health Records
- Emergency Medicine
- End of Life, Hospice, Palliative Care
- Environmental Health
- Equity, Diversity, and Inclusion
- Facial Plastic Surgery
- Gastroenterology and Hepatology
- Genetics and Genomics
- Genomics and Precision Health
- Global Health
- Guide to Statistics and Methods
- Hair Disorders
- Health Care Delivery Models
- Health Care Economics, Insurance, Payment
- Health Care Quality
- Health Care Reform
- Health Care Safety
- Health Care Workforce
- Health Disparities
- Health Inequities
- Health Policy
- Health Systems Science
- History of Medicine
- Hypertension
- Images in Neurology
- Implementation Science
- Infectious Diseases
- Innovations in Health Care Delivery
- JAMA Infographic
- Law and Medicine
- Leading Change
- Less is More
- LGBTQIA Medicine
- Lifestyle Behaviors
- Medical Coding
- Medical Devices and Equipment
- Medical Education
- Medical Education and Training
- Medical Journals and Publishing
- Mobile Health and Telemedicine
- Narrative Medicine
- Neuroscience and Psychiatry
- Notable Notes
- Nutrition, Obesity, Exercise
- Obstetrics and Gynecology
- Occupational Health
- Ophthalmology
- Orthopedics
- Otolaryngology
- Pain Medicine
- Palliative Care
- Pathology and Laboratory Medicine
- Patient Care
- Patient Information
- Performance Improvement
- Performance Measures
- Perioperative Care and Consultation
- Pharmacoeconomics
- Pharmacoepidemiology
- Pharmacogenetics
- Pharmacy and Clinical Pharmacology
- Physical Medicine and Rehabilitation
- Physical Therapy
- Physician Leadership
- Population Health
- Primary Care
- Professional Well-being
- Professionalism
- Psychiatry and Behavioral Health
- Public Health
- Pulmonary Medicine
- Regulatory Agencies
- Reproductive Health
- Research, Methods, Statistics
- Resuscitation
- Rheumatology
- Risk Management
- Scientific Discovery and the Future of Medicine
- Shared Decision Making and Communication
- Sleep Medicine
- Sports Medicine
- Stem Cell Transplantation
- Substance Use and Addiction Medicine
- Surgical Innovation
- Surgical Pearls
- Teachable Moment
- Technology and Finance
- The Art of JAMA
- The Arts and Medicine
- The Rational Clinical Examination
- Tobacco and e-Cigarettes
- Translational Medicine
- Trauma and Injury
- Treatment Adherence
- Ultrasonography
- Users' Guide to the Medical Literature
- Vaccination
- Venous Thromboembolism
- Veterans Health
- Women's Health
- Workflow and Process
- Wound Care, Infection, Healing
- Register for email alerts with links to free full-text articles
- Access PDFs of free articles
- Manage your interests
- Save searches and receive search alerts
Search Results
Barnboken: tidskrift för barnlitteraturforskning, intersectionalities-a global journal of social work analysis research polity and practice, trabajo social global-global social work, journal of global economic analysis, journal of global analysis, journal of global economic analysis, annals of global analysis and geometry, annals of global analysis and geometry, global and stochastic analysis, lihua jianyan: huaxue fence/physical testing and chemical analysis part b:chemical analysis, policy analysis brief. w series / project hope, walsh center for rural health analysis, childhood-a global journal of child research, journal of global entrepreneurship research, journal of global mobility-the home of expatriate management research, journal of the american academy of orthopaedic surgeons global research and reviews.
Not getting the journal you are searching for? So it most likely not indexed in Scopus, WOS, PubMed, DOAJ, UGC CARE. You might also try:
- Enter the correct title.
- Check the spelling of the words
- Make sure you have added spaces between words
TOP RESEARCH JOURNALS
- Agricultural & Biological Sciences
- Arts & Humanities
- Business, Management and Accounting
- Computer Science
- Engineering
- Mathematics
- Social Sciences
| in a scored and prestigious database of scientific journals. This section allows you to place information about the journal, editors, and publisher, etc. from all over the world. | Area: Evaluated version: online | |||
| The journal is indexed in: | ||||
| SJIFactor.com | ||||
| Basic information | ||||
| Main title | ||||
| ISSN | 2277-8160 (E) / 2277-8160 (P) | |||
| URL | ||||
| Country | Scientific | --!>|||
| Frequency | Monthly | |||
| License | Free for non-commercial use | |||
| Texts availability | Free | |||
| Journal's description | ||||
Date: Sunday, June 16 th , 2024
Time: 05:16 AM
+91 88 66 00 3636
- Editorial Board
Author Guidelines
- Publication Charges
- Past Issues
- Submit for June Issue & get it published in 3 Working Days
- NATIONAL MEDICAL COMMISSION (NMC) VALID PUBLICATION
Upload your Article
- Book Publication
- Current Issue Current Issue -->
- Subscription Form
- Sister Journals
| 2021 | |||
|---|---|---|---|
| 2020 | |||
|---|---|---|---|
| 2019 | |||
|---|---|---|---|
| 2018 | |||
|---|---|---|---|
| 2017 | |||
|---|---|---|---|
| 2016 | |||
|---|---|---|---|
| 2015 | |||
|---|---|---|---|
| 2014 | |||
|---|---|---|---|
| 2013 | |||
|---|---|---|---|
| 2012 | |||
|---|---|---|---|
Latest News
Call for papers...
GJRA invites high-quality Research Papers/Articles for October-2020 Issue....
August Issue Released ...
Dear Colleague, August issue of Global Journal For Research Analysis is released...thank you very much for your intellectual contribution....
IJAR invites high-quality Research Papers/Articles for August-2016 Issue...
sc_online_t(1526970,"","3b4076"); --> Subscribe to our Newsletter
Our other journals....
- Submit a Manuscript
- Advanced search
American Journal of Neuroradiology
Advanced Search
MR Imaging Findings in Anti-Leucine-Rich Glioma Inactivated Protein 1 Encephalitis: A Systematic Review and Meta-analysis
- Find this author on Google Scholar
- Find this author on PubMed
- Search for this author on this site
- ORCID record for Francisco C. Almeida
- ORCID record for Raquel Samões
- ORCID record for Tiago Gil Oliveira
- Figures & Data
- Supplemental
- Info & Metrics
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
BACKGROUND: Antibodies against leucine-rich glioma inactivated protein 1 (LGI1) constitute a common form of autoimmune encephalitis. On MR imaging, it may show T2 FLAIR hyperintensities of the medial temporal lobe (T2 FLAIR-MTL), involve the basal ganglia, or be unremarkable.
PURPOSE: We performed a systematic review and meta-analysis to obtain prevalence estimates of abnormal findings on MR imaging in anti-LGI1 encephalitis. A human brain map of the LGI1 microarray gene expression was derived from the Allen Human Brain Atlas.
DATA SOURCES: PubMed and Web of Science were searched with the terms “LGI1” and “encephalitis” from inception to April 7, 2022.
STUDY SELECTION: Thirty-one research publications, encompassing case series and retrospective cohort and case-control studies, with >10 patients with anti-LGI1 encephalitis and MR imaging data were included.
DATA ANALYSIS: Pooled prevalence estimates were calculated using Freeman-Tukey double-arcsine transformation. Meta-analysis used DerSimonian and Laird random effects models.
DATA SYNTHESIS: Of 1318 patients in 30 studies, T2 FLAIR-MTL hyperintensities were present in 54% (95% CI, 0.48–0.60; I 2 = 76%). Of 394 patients in 13 studies, 27% showed bilateral (95% CI, 0.19–0.36; I 2 = 71%) and 24% unilateral T2 FLAIR-MTL abnormalities (95% CI, 0.17–0.32; I 2 = 61%). Of 612 patients in 15 studies, basal ganglia abnormalities were present in 10% (95% CI, 0.06–0.15; I 2 = 67%). LGI1 expression was highest in the amygdala, hippocampus, and caudate nucleus.
LIMITATIONS: Only part of the spectrum of MR imaging abnormalities in anti-LGI1 encephalitis could be included in a meta-analysis. MR imaging findings were not the main outcomes in most studies, limiting available information. I 2 values ranged from 62% to 76%, representing moderate-to-large heterogeneity.
CONCLUSIONS: T2 FLAIR-MTL hyperintensities were present in around one-half of patients with anti-LGI1. The prevalence of unilateral and bilateral presentations was similar, suggesting unilaterality should raise the suspicion of this disease in the appropriate clinical context. Around 10% of patients showed basal ganglia abnormalities, indicating that special attention should be given to this region. LGI1 regional expression coincided with the most frequently reported abnormal findings on MR imaging. Regional specificity might be partially determined by expression levels of the target protein.
- ABBREVIATIONS:
Raquel Samões and Tiago Gil Oliveira contributed equally to this work.
Disclosure forms provided by the authors are available with the full text and PDF of this article at www.ajnr.org .
- © 2024 by American Journal of Neuroradiology
Log in using your username and password
Thank you for your interest in spreading the word on American Journal of Neuroradiology.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.
Citation Manager Formats
- EndNote (tagged)
- EndNote 8 (xml)
- RefWorks Tagged
- Ref Manager
- Tweet Widget
- Facebook Like
- Google Plus One
Jump to section
- MATERIALS AND METHODS
- CONCLUSIONS
- Acknowledgments
Related Articles
- Google Scholar
Cited By...
- No citing articles found.
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
- Investigating Sea-Level Brain Predictors for Acute Mountain Sickness: A Multimodal MRI Study before and after High-Altitude Exposure
- Structural Brain MR Imaging Alterations in Patients with Systemic Lupus Erythematosus with and without Neuropsychiatric Events
Similar Articles
+91 88 66 00 3636
Publishes on 15 th Day Of The Month
- Editorial Board
Author Guidelines
- Indexing & Abstracting
- Past Issues
- Publication ethics
- PUBLISH YOUR PAPER IN 3 WORKING DAYS
Upload your Article
- Book Publication
- Current Issue
- Subscription Form
- Peer Review Process
- Sister Journals
About Us - GJRA
- Aim and Scope
- Editorial and Peer Review Processes
- Editorial Board Members
- Experience Of Editorial Board Members
- Guidelines for Authors
- Open Access
- Conflict of interest and funding
- Human and Animal Rights
- Inform Consent
- Copyright assignment
- Why Publish Your Article in Global Journal For Research Analysis
- Advertising polices for print and web publications
Global Journal For Research Analysis (GJRA) is a double reviewed monthly print journal that accepts research works from scholars, academicians, professors, doctorates, lecturers, and corporate in their respective expertise of studies. Work after publication will be retrievable on the website bifurcated based on issues of the month and its publication date. Moreover, the journal serves the research world since October, 2011.
The journal is wide and available for diverse intellectual and educational pursuit from all corners of the society to enrich the learning experience of the group readers.
The periphery of the subject areas includes:
| Accountings | Finance |
| Management Accounting | Business |
| Commerce | Corporate Governance |
| Financial Accounting | Arts |
| Fine Arts | Designing |
| Medical | Bio-medical |
| clinical research | home science |
| Medical science | Psychology |
| Human ideology | Sociology |
| Economics | Education |
| Engineering | Electronics |
| Electrical | Information technology |
| Computer Science | Management |
| Organization behaviour | Organization psychology |
| Marketing management | Law |
| Corporate | Human Resources |
| Geography | History |
| Intellectual Property Rights | Industrial Laws |
| Journalism | Literature |
| Philosophy | Pharmaceutical Science |
| Political Science | Rural India |
| Statistics | Social Sciences |
Global Journal For Research Analysis a double blind peer review. Referees remain anonymous for the author during the review procedure and the authors name is removed from the manuscript under review.
Only after publication, and only with the permission of the referee, the names of the reviewers are published in the article.
Each article is first assessed by two of the editors of the editorial board and, if it is judged suitable for GJRA, it is sent to two or three external referees for a double blind peer review. GJRA uses three different review forms (Research and Theory, Integrated Care Cases, Policy papers) all of which apply scientific criteria and take account of the purpose of the article and its merits for integrated care.
Based on the recommendations of the reviewers, the editors then decide whether the paper should be accepted as is, revised or rejected. In case of revisions, a final decision on publication will be made after resubmission. If there is no agreement on the part of the editors, the editor-in-chief will make the final decision.
We have mention our Editorial Board Members name here: Editorial Board Members
Our Editorial board members having minimum 10 years of rich experience in scholarly publishing in general and life science.
Format & Style:
Manuscripts:
All manuscripts must be printed in letter quality (font size 12) in double space on one side of A4 paper with margins of at least one inch on all sides.
Cover Page:
Manuscripts of a paper should have a cover page providing the title of the paper, the name(s), address, phone, fax numbers and e-mail address of all authors and acknowledgments, if any. Please restrict the author related information only to cover page. Further, please mention the subject under which the paper should be included.
Following the cover page, there should be an "abstract" page, which should contain the title of paper, the subtitle "Abstract" and a summary of the paper in double space. It should not exceed 150 words in length along with three to four key words. The text of the paper should not start on this page, but on a fresh page. References should be cited in the style prescribed in the publication manual of the American Psychological Association (APA Guidelines). Please visit URL: http://www.library.cornell.edu/resrch/citmanage/apa
Figures & Tables:
Each figure/table should be numbered, titled. The position of figure or table should be indicated in the text on a separate line with the words "Table 1 about here"
Length of the Papers:
The total length of the paper should not exceed 2000 words (Includes maximum 2 to 3 charts/table/figures in total, paper with more charts/table/figure shall have to pay atleast Rs.500/- extra). For every additional 750 words an extra Rs. 500/- will be charged.
Publication Fees:
GJRA charges a humble amount towards publication fees of Rs. 1500/- for single author upto 2000 words, for every Addition author Rs. 500/- extra to be paid and/or for every additional 750 words Rs.500 extra, to be paid.
For International Authors (Authors outside India) needs to pay US$ 100 for single author for an article with a length of 2000 words. However, for every additional author US$ 50 extra to be paid and/or every additional 750 words an extra US$ 50 needs to be paid.
Open access publishing The GJRA is an open access publication and its content is therefore free for anybody to access online, to read and download, as well as to copy and disseminate for educational purposes. Articles are published immediately upon acceptance and production of the final formatted version. When published online
We have indexed in following Indexing sites
| Pubmed Central | Index Medicus |
| Indian Citation Index | DJOF |
| DRJI | Cite Factor |
| Google Scholar | Genamics |
| EZ3 | Open J-Gate |
| Cross Ref | I2OR |
| INDIAN SOCIETY FOR HEALTH AND ADVANCED RESEARCH | |
Authors are responsible for recognizing and disclosing financial and other conflicts of interest that might bias their work. They should acknowledge in the manuscript all financial support for the work and other financial or personal connections to the work.
Public trust in the peer review process and the credibility of published articles depend in part on how well conflict of interest is handled during writing, peer review, and editorial decision making. Conflict of interest exists when an author (or the authors institution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from those with negligible potential to those with great potential to influence judgment, and not all relationships represent true conflict of interest. The potential for conflict of interest can exist whether or not an individual believes that the relationship affects his or her scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself. However, conflicts can occur for other reasons, such as personal relationships, academic competition, and intellectual passion.
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.
Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify Individuals who provide writing assistance and disclose the funding source for this assistance.
Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.
The requirement for informed consent should be included in the journals instructions for authors. When informed consent has been obtained it should be indicated in the published article.
Papers are accepted for publication on the understanding that exclusive copyright in the paper is assigned to the Publisher. Authors are asked to sign a copyright assignment form after acceptance of their papers.
High visibility
Global Journal For Research Analysiss open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a Highly accessed graphic, which appears on the journals contents pages and search results.
Speed of publication
Global Journal For Research Analysis offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Global Journal For Research Analysis
Flexibility
Online publication in Global Journal For Research Analysis gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
All advertisements and commercially sponsored publications are independent from editorial decisions. Global Journal For Research Analysis does not endorse any product or service marked as an advertisement or promoted by a sponsor in Global Journal For Research Analysis publications. Editorial content is not compromised by commercial or financial interests, or by any specific arrangements with advertising clients or sponsors.
Global Journal For Research Analysis reserves the right to decline any type of advertising that is damaging to the brand of Global Journal For Research Analysis or is inappropriate to the content held on the Global Journal For Research Analysis network.
Global Journal For Research Analysis will not accept advertising for products or services known to be harmful to health (e.g. tobacco and alcohol products).
Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Publisher requests its removal.
Global Journal For Research Analysis will not allow any treatment-specific or drug-specific campaign to be targeted to a specific article(s) or on any page where content relates to the product(s) being advertised. (Advertisers may not link to articles using keywords; they may not target advertising for a specific product on the condition that it appear in the same location and at the same time as a specific article mentioning that product and they may not refer to an article published at the same time as the advertisement appears).
If any advert is requested outside of Global Journal For Research Analysis standard advertising positions then a request should be made to editorial who will respond with a full and final decision within two business days.
UGC CARE JOURNAL APPROVAL STATUS
Qualis approved journal-brazil, click here.
Journal Template
Latest News sc_online_i(1621729,"3b4076;","3b4076;"); free online counter
Call for papers...
GJRA invites high-quality Research Papers/Articles for July-2024 Issue. ...
June Issue Released...
Dear Colleague, June issue of Global Journal For Research Analysis is released...thank you very much for your intellectual contribution. ...
sc_online_t(1526970,"","FFFFFF");
Subscribe to our newsletter, our other journals....
An official website of the United States government
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
- Publications
- Account settings
- My Bibliography
- Collections
- Citation manager
Save citation to file
Email citation, add to collections.
- Create a new collection
- Add to an existing collection
Add to My Bibliography
Your saved search, create a file for external citation management software, your rss feed.
- Search in PubMed
- Search in NLM Catalog
- Add to Search
Creatine Supplementation and Upper Limb Strength Performance: A Systematic Review and Meta-Analysis
Affiliations.
- 1 Preventive and Occupational Medicine, University Hospital of Clermont-Ferrand (CHU), 58 rue Montalembert, Clermont-Ferrand, France.
- 2 CNRS UMR 6024, Physiological and Psychosocial Stress, LAPSCO, Clermont-Ferrand, France.
- 3 Clinical Research and Innovation Direction, University Hospital of Clermont-Ferrand (CHU), Clermont-Ferrand, France.
- 4 School of Exercise Science, Australian Catholic University, Melbourne, VIC, Australia.
- 5 Neurophysiology of Stress, Armies' Biomedical Research Institute, Armies' Health Service, Bretigny sur Orge, France.
- 6 Occupational Medicine, University Hospital of Montpellier (CHU), Montpellier, France.
- 7 School of Exercise Science, Australian Catholic University, Melbourne, VIC, Australia. [email protected].
- 8 Preventive and Occupational Medicine, University Hospital of Clermont-Ferrand (CHU), 58 rue Montalembert, Clermont-Ferrand, France. [email protected].
- 9 CNRS UMR 6024, Physiological and Psychosocial Stress, LAPSCO, Clermont-Ferrand, France. [email protected].
- 10 Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological Conditions EA3533, University Clermont Auvergne, Clermont-Ferrand, France. [email protected].
- 11 CRNH Auvergne, Clermont-Ferrand, France. [email protected].
- PMID: 27328852
- DOI: 10.1007/s40279-016-0571-4
Background: Creatine is the most widely used supplementation to increase performance in strength; however, the most recent meta-analysis focused specifically on supplementation responses in muscles of the lower limbs without regard to upper limbs.
Objective: We aimed to systematically review the effect of creatine supplementation on upper limb strength performance.
Methods: We conducted a systematic review and meta-analyses of all randomized controlled trials comparing creatine supplementation with a placebo, with strength performance measured in exercises shorter than 3 min in duration. The search strategy used the keywords 'creatine', 'supplementation', and 'performance'. Independent variables were age, sex and level of physical activity at baseline, while dependent variables were creatine loading, total dose, duration, time interval between baseline (T0) and the end of the supplementation (T1), and any training during supplementation. We conducted three meta-analyses: at T0 and T1, and on changes between T0 and T1. Each meta-analysis was stratified within upper limb muscle groups.
Results: We included 53 studies (563 individuals in the creatine supplementation group and 575 controls). Results did not differ at T0, while, at T1, the effect size (ES) for bench press and chest press were 0.265 (95 % CI 0.132-0.398; p < 0.001) and 0.677 (95 % CI 0.149-1.206; p = 0.012), respectively. Overall, pectoral ES was 0.289 (95 % CI 0.160-0.419; p = 0.000), and global upper limb ES was 0.317 (95 % CI 0.185-0.449; p < 0.001). Meta-analysis of changes between T0 and T1 gave similar results. The meta-regression showed no link with characteristics of population or supplementation, demonstrating the efficacy of creatine independently of all listed conditions.
Conclusion: Creatine supplementation is effective in upper limb strength performance for exercise with a duration of less than 3 min, independent of population characteristics, training protocols, and supplementary doses or duration.
PubMed Disclaimer
Similar articles
- Effect of vitamin D supplementation on upper and lower limb muscle strength and muscle power in athletes: A meta-analysis. Zhang L, Quan M, Cao ZB. Zhang L, et al. PLoS One. 2019 Apr 30;14(4):e0215826. doi: 10.1371/journal.pone.0215826. eCollection 2019. PLoS One. 2019. PMID: 31039170 Free PMC article.
- Creatine Supplementation and Lower Limb Strength Performance: A Systematic Review and Meta-Analyses. Lanhers C, Pereira B, Naughton G, Trousselard M, Lesage FX, Dutheil F. Lanhers C, et al. Sports Med. 2015 Sep;45(9):1285-1294. doi: 10.1007/s40279-015-0337-4. Sports Med. 2015. PMID: 25946994 Review.
- Creatine but not betaine supplementation increases muscle phosphorylcreatine content and strength performance. del Favero S, Roschel H, Artioli G, Ugrinowitsch C, Tricoli V, Costa A, Barroso R, Negrelli AL, Otaduy MC, da Costa Leite C, Lancha-Junior AH, Gualano B. del Favero S, et al. Amino Acids. 2012 Jun;42(6):2299-305. doi: 10.1007/s00726-011-0972-5. Epub 2011 Jul 9. Amino Acids. 2012. PMID: 21744011 Clinical Trial.
- Creatine supplementation for patients with COPD receiving pulmonary rehabilitation: a systematic review and meta-analysis. Al-Ghimlas F, Todd DC. Al-Ghimlas F, et al. Respirology. 2010 Jul;15(5):785-95. doi: 10.1111/j.1440-1843.2010.01770.x. Epub 2010 May 20. Respirology. 2010. PMID: 20497386 Review.
- Effect of creatine supplementation on body composition and performance: a meta-analysis. Branch JD. Branch JD. Int J Sport Nutr Exerc Metab. 2003 Jun;13(2):198-226. doi: 10.1123/ijsnem.13.2.198. Int J Sport Nutr Exerc Metab. 2003. PMID: 12945830
- Completely Plant-Based Diets That Meet Energy Requirements for Resistance Training Can Supply Enough Protein and Leucine to Maximize Hypertrophy and Strength in Male Bodybuilders: A Modeling Study. Goldman DM, Warbeck CB, Karlsen MC. Goldman DM, et al. Nutrients. 2024 Apr 10;16(8):1122. doi: 10.3390/nu16081122. Nutrients. 2024. PMID: 38674813 Free PMC article.
- Prevalence of dietary supplement consumption among CrossFit practitioners. Dos Santos Quaresma MVL, Marques CG, Magalhães ACO, Cirillo L, Ciudi RB, Oliveira LS, Dos Santos RVT, Nakamoto FP. Dos Santos Quaresma MVL, et al. Nutrire. 2023;48(1):9. doi: 10.1186/s41110-023-00193-z. Epub 2023 Feb 13. Nutrire. 2023. PMID: 38625281 Free PMC article.
- High-dose short-term creatine supplementation without beneficial effects in professional cyclists: a randomized controlled trial. Barranco-Gil D, Alejo LB, Revuelta C, Górriz M, Pagola I, Ozcoidi LM, Lucia A, Valenzuela PL. Barranco-Gil D, et al. J Int Soc Sports Nutr. 2024 Dec;21(1):2340574. doi: 10.1080/15502783.2024.2340574. Epub 2024 Apr 12. J Int Soc Sports Nutr. 2024. PMID: 38606895 Free PMC article. Clinical Trial.
- Glucose ingestion before and after resistance training sessions does not augment ribosome biogenesis in healthy moderately trained young adults. Lian K, Hammarström D, Hamarsland H, Mølmen KS, Moen SC, Ellefsen S. Lian K, et al. Eur J Appl Physiol. 2024 Mar 8. doi: 10.1007/s00421-024-05446-x. Online ahead of print. Eur J Appl Physiol. 2024. PMID: 38459192
- Athletes' nutritional demands: a narrative review of nutritional requirements. Amawi A, AlKasasbeh W, Jaradat M, Almasri A, Alobaidi S, Hammad AA, Bishtawi T, Fataftah B, Turk N, Saoud HA, Jarrar A, Ghazzawi H. Amawi A, et al. Front Nutr. 2024 Jan 18;10:1331854. doi: 10.3389/fnut.2023.1331854. eCollection 2023. Front Nutr. 2024. PMID: 38328685 Free PMC article. Review.
- J Appl Physiol (1985). 1997 Dec;83(6):2055-63 - PubMed
- J Hum Kinet. 2014 Nov 12;43:131-8 - PubMed
- Endocrine. 2014 Apr;45(3):354-61 - PubMed
- Philos Trans R Soc Lond B Biol Sci. 2011 Jun 27;366(1572):1790-8 - PubMed
- Med Sci Sports Exerc. 2002 Mar;34(3):537-43 - PubMed
Publication types
- Search in MeSH
Related information
- PubChem Compound (MeSH Keyword)
LinkOut - more resources
Full text sources, other literature sources.
- scite Smart Citations
- MedlinePlus Health Information
- Citation Manager
NCBI Literature Resources
MeSH PMC Bookshelf Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
COMMENTS
PubMed is a comprehensive database of biomedical literature from various sources, including MEDLINE, life science journals, and online books. You can search for citations, access full text content, and explore topics related to health, medicine, and biology. PubMed also provides advanced search options and tools for researchers and clinicians.
Global Journal For Research Analysis (GJRA) Global Journal For Research Analysis (GJRA) is a double reviewed monthly print journal that accepts research works from scholars, academicians, professors, doctorates, lecturers, and corporate in their respective expertise of studies.Work after publication will be retrievable on the website bifurcated based on issues of the month and its publication ...
World Wide Journals was founded in Ahmedabad (India) in 2011.Find details about Editorial Policies,Global Journal For Research Analysis (GJRA),GJRA. International Journal. Global Journal For Research Analysis PRINT ISSN NO 2277 - 8160 IF OF GJRA: 5.956 (SJIF) ... to PubMed, to sequence and other databases, and to other articles). ...
Find details about Author Guidelines,Global Journal For Research Analysis (GJRA),GJRA. Journal for all subject. Global Journal For Research Analysis "IF of GJRA : 5.956 (SJIF-2019)" PRINT ISSN No 2277 - 8160 Index Copernicus IC Value : 70.36. Date: Tuesday, June 11 th, 2024. Time: 20:53 PM. [email protected]
TriNetX is a growing global network, expanding from 55 HCOs and 7 countries in 2017 to over 220 HCOs and 30 countries in 2022. Over 19 000 sponsored clinical trial opportunities have been initiated through the TriNetX network. There have been over 350 peer-reviewed scientific publications based on the network's data.
Global Journal For Research Analysis "IF of GJRA : 5.956 (SJIF-2019)" PRINT ISSN No 2277 - 8160 Index Copernicus IC Value : 70.36 Date: Tuesday, June 11 th , 2024
Type the journal title or ISSN on the search box and click on the search button. The journal details will be shown if it is in the National Library of Medicine (NLM) catalog. Check the "Current indexing status.". Indexed journal shows "Currently indexed for MEDLINE". PubMed Central (PMC)
Last modification date: 08/02/2016 Type of record: Confirmed ISSN Center responsible of the record: ISSN National Centre for India Please contact this ISSN Centre by clicking on it for any request or query concerning the publication
1. Title Abbreviation: Glob J Res Anal Title(s): Global journal for research analysis. Publication Start Year: 2012 Publication End Year: Country of Publication: India Publisher: Ahmedabad : Sara Publishing Academy Language: English ISSN: 2277-8160(Electronic); 2277-8160(Linking) Electronic Links: Access not provided by NLM In: PubMed: Selected citations only Current Indexing Status: Not ...
Global Journal For Research Analysis Latest Publications. TOTAL DOCUMENTS. 943 (FIVE YEARS 0) H-INDEX. 4 (FIVE YEARS 0) Published By The Global Journals. 2277-8160, 2277-8160 Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords Latest Documents;
Global Journal For Research Analysis "IF of GJRA : 5.956 (SJIF-2019)" PRINT ISSN No 2277 - 8160 Index Copernicus IC Value : 70.36 Date: Saturday, June 8 th , 2024
No studies have addressed research collaboration in network meta-analysis (NMA). In this study, we used social network analysis methods to characterize global collaboration patterns of published NMAs over the past decades. Methods: PubMed, EMBASE, Web of Science and the Cochrane Library were searched (at 9th July, 2015) to include systematic ...
This systematic review and meta-analysis of randomized controlled trials (RCTs) was performed to summarize the effect of caffeine intake on weight loss. We searched the following databases until November 2017: MEDLINE, EMBASE, Web of Science, and Cochrane Central Register of Controlled Trials. The r …
Global Journal For Research Analysis (GJRA) Global Journal For Research Analysis (GJRA) is a double reviewed monthly print journal that accepts research works from scholars, academicians, professors, doctorates, lecturers, and corporate in their respective expertise of studies.Work after publication will be retrievable on the website bifurcated based on issues of the month and its publication ...
Global Journal For Research Analysis-GJRA,More Details on World Wide Journals. International Journal. Global Journal For Research Analysis PRINT ISSN NO 2277 - 8160 IF OF GJRA: 5.956 (SJIF) PEER REVIEW, INTERNATIONAL JOURNAL Journal DOI : 10.36106/gjra. Monday, Jun,10 th, 2024 .
Kidney stone disease is a crystal concretion formed usually within the kidneys. It is an increasing urological disorder of human health, affecting about 12% of the world population. It has been associated with an increased risk of end-stage renal failure. The etiology of kidney stone is multifactorial. The most common type of kidney stone is ...
Global Journal For Research Analysis-GJRA,More Details on World Wide Journals. Journal for all subject. Global Journal For Research Analysis "IF of GJRA : 5.956 (SJIF-2019)" PRINT ISSN No 2277 - 8160 Index Copernicus IC Value : 70.36. Date: Wednesday, June 12 th, 2024. Time: 18:08 PM. [email protected]
Random-effects meta-analysis was conducted using Meta-Essentials version 1.5 for Microsoft Excel (Erasmus Research Institute of Management). 53 A random-effects model was chosen given the high expected heterogeneity of included studies. Odds ratios (OR) were used as the indicator of effect size.
This systematic review and meta-analysis of randomized controlled trials (RCTs) was performed to summarize the effect of ginger intake on weight loss, glycemic control and lipid profiles among overweight and obese subjects. We searched the following databases through November 2017: MEDLINE, EMBASE, …
This Viewpoint from the FDA discusses how pragmatic clinical research—assessment that uses real-world data, often in combination with research data, after initial marketing approval—can help in evaluation of new technologies, benefit research sites in underresourced settings, and better inform...
Journal of Global Analysis E-ISSN: 2041-1944 Publisher: Centre for Strategic Research & Analysis Journal of Global Economic Analysis E-ISSN: 23772999 Publisher: Purdue University, Department of Agricultural Economics ANNALS OF GLOBAL ANALYSIS AND GEOMETRY E-ISSN: 1572-9060 Publisher: SPRINGER Annals of Global Analysis and Geometry E-ISSN: 15729060
SJIF Value - Global Journal For Research Analysis (GJRA) is a double reviewed monthly print journal that accepts research works from scholars, academicians, professors, doctorates, lecturers, and corporate in their respective expertise of studies. Work after publication will be retrievable on the website bifurcated based on issues of the month and its publication date.
Degenerative cervical myelopathy (DCM) is the most prevalent spinal cord disorder resulting in significant neurologic dysfunctions and is a leading cause of cervical spine surgical procedures. 1,2 Despite progress in medical knowledge, there remains a critical need for non-invasive, reliable measures for evaluating the condition of the spinal cord in patients with DCM. 3,4 While magnetic ...
Find details about MCI Apprived Journal,Global Journal For Research Analysis (GJRA),GJRA. Journal for all subject. Global Journal For Research Analysis "IF of GJRA : 5.956 (SJIF-2019)" PRINT ISSN No 2277 - 8160 Index Copernicus IC Value : 70.36. Date: Wednesday, June 5 th, 2024. Time: 11:35 AM. [email protected]
This study aims to assess the pattern of long COVID research literature, analyze the research topics, and provide insights on long COVID. In this study, we extracted 784 publications from Scopus in the field of long COVID. According to bibliometric analysis, it is found that: developed countries in Europe and America were in leading positions ...
BACKGROUND: Antibodies against leucine-rich glioma inactivated protein 1 (LGI1) constitute a common form of autoimmune encephalitis. On MR imaging, it may show T2 FLAIR hyperintensities of the medial temporal lobe (T2 FLAIR-MTL), involve the basal ganglia, or be unremarkable. PURPOSE: We performed a systematic review and meta-analysis to obtain prevalence estimates of abnormal findings on MR ...
Department of Public Health and Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark ... Full access to the journal is a member benefit for ASN Members, ... a global modelling analysis with country-level detail. Lancet Planet. Health. 2018; 2: e451 ...
World Wide Journals was founded in Ahmedabad (India) in 2011.Find details about Editorial Policies,Global Journal For Research Analysis (GJRA),GJRA. International Journal. Global Journal For Research Analysis PRINT ISSN NO 2277 - 8160 IF OF GJRA: 5.956 (SJIF) ... to PubMed, to sequence and other databases, and to other articles). ...
Overall, pectoral ES was 0.289 (95 % CI 0.160-0.419; p = 0.000), and global upper limb ES was 0.317 (95 % CI 0.185-0.449; p < 0.001). Meta-analysis of changes between T0 and T1 gave similar results. The meta-regression showed no link with characteristics of population or supplementation, demonstrating the efficacy of creatine independently of ...
An AI system was superior to radiologists using PI-RADS (2.1), on average, at detecting clinically significant prostate cancer and comparable to the standard of care. Such a system shows the potential to be a supportive tool within a primary diagnostic setting, with several associated benefits for patients and radiologists. Prospective validation is needed to test clinical applicability of ...